Bioethics FDA Featured Health Law Policy History Intellectual Property Pharmaceuticals Professional Regulation Public Health Reimbursement Research Funding Resource Allocation Vaccines
NIH
-
-
How Soon Could President Biden Enable Generic Competition to Xtandi? Very Quickly, If There Is the Will.
Read more: How Soon Could President Biden Enable Generic Competition to Xtandi? Very Quickly, If There Is the Will. -
Empirical Featured Human Subjects Research Leah Pierson Public Health Race Research Funding Scientific EvidenceThe NIH Has the Opportunity to Address Research Funding Disparities
Read more: The NIH Has the Opportunity to Address Research Funding Disparities -
Bioethics FDA Featured Health Law Policy History HIV/AIDS Intellectual Property Jorge Contreras Pharmaceuticals Public HealthWhat Ever Happened to NIH’s “Fair Pricing” Clause?
Read more: What Ever Happened to NIH’s “Fair Pricing” Clause? -
COVID-19 Highlights Need for Rights to Repair and Produce in Emergencies
Read more: COVID-19 Highlights Need for Rights to Repair and Produce in Emergencies -
Novartis, Dana Farber, Oregon Health & Science University Wait 18 Years to Disclose NIH Funding in Key Gleevec Patent
Read more: Novartis, Dana Farber, Oregon Health & Science University Wait 18 Years to Disclose NIH Funding in Key Gleevec Patent -
Government Shutdown: Why the Pipeline Matters
Read more: Government Shutdown: Why the Pipeline Matters -
Empirical Funding Opportunities Health Law Policy Public Health Public Health Law Research Research Funding Scott Burris
More on NSF and NIH Funding
Read more: More on NSF and NIH Funding -
While We Sleep?
Read more: While We Sleep? -
Birth Control for Men?
Read more: Birth Control for Men?